Abstract

Many years of experience in using fixed combinations of topical glucocorticosteroids in dermatology today seem to be justified not only theoretically (the pathogenesis of immuno-inflammatory and infectious dermatoses), but also from the perspective of optimizing therapeutic measures in this category of patients. From this position, the innovative combination drug Tetraderm® can be regarded as the drug of choice for dermatoses of combined etiology. The composition of the drug includes highly effective components that allow you to affect the inflammatory component, infection and trophic tissue in the lesions. The components of the drug show a favorable profile of antibacterial and antimycotic activity. Highly potent corticosteroid can effectively stop inflammation. The drug has prospects for use in various dermatoses of combined etiology (atopic dermatitis, eczema), in clinical situations when mycoses or pyoderma have signs of eczematization of the process, rashes in large folds, cystic dermatoses and diskeratoses.

Highlights

  • the innovative combination drug Tetraderm® can be regarded as the drug of choice

  • The components of the drug show a favorable profile of antibacterial

  • Anogenital itching is a serious problem for most women

Read more

Summary

Actual recommendations for multicomponent drug use in dermatology

С этой позиции инновационный комбинированный препарат Тетрадерм® можно расценивать как препарат выбора при дерматозах сочетанной этиологии. Перспективы применения препарат имеет при различных дерматозах сочетанной этиологии (атопический дерматит, экзема), в клинических ситуациях, когда микозы или пиодермии имеют признаки экзематизации процесса, высыпания в крупных складках, пузырные дерматозы и дискератозы. Ключевые слова: дерматозы сочетанной этиологии, пиодермии, микозы, комбинированный препарат, Тетрадерм®. Summary Many years of experience in using fixed combinations of topical glucocorticosteroids in dermatology today seem to be justified theoretically (the pathogenesis of immuno-inflammatory and infectious dermatoses), and from the perspective of optimizing therapeutic measures in this category of patients From this position, the innovative combination drug Tetraderm® can be regarded as the drug of choice for dermatoses of combined etiology. Препарат Вазоконстрикция Сравнительная эффективность при АД Общая оценка эффективности (Э)

Атрофия кожи Влияние на системный баланс ГКС
Комбинированные с кортикостероидами препараты
Материал для тестирования
Чувствительность штаммов к Эконазолу
Список литературы
Принципы диагностики и терапии аногенительного зуда у женщин
Findings
Principles of diagnostics and therapy of anogenital pruritus in women
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.